How should low DHEA‑Sulfate be evaluated and managed in a male patient?

Evaluation and Management of Low DHEA-Sulfate in Male Patients

Low DHEA-sulfate in a male patient requires measurement of morning total testosterone and assessment for symptoms of hypogonadism, followed by determination of whether the patient has primary versus secondary adrenal/gonadal insufficiency through LH, FSH, and cortisol testing.

Initial Clinical Assessment

When encountering low DHEA-S in a male patient, focus your evaluation on:

• Symptoms of hypogonadism: decreased libido, erectile dysfunction, fatigue, muscle weakness, mood changes 1, 2
• Signs of adrenal insufficiency: salt cravings, orthostatic hypotension, weight loss, hyperpigmentation
• Metabolic comorbidities: obesity, diabetes, metabolic syndrome (these commonly cause functional hypogonadism) 1
• Medications and substances: glucocorticoids, opioids, antiretroviral therapy, anabolic steroids 1
• Acute illness status: avoid testing during acute illness as it suppresses the hypothalamic-pituitary axis 1

Diagnostic Algorithm

Step 1: Confirm Low DHEA-S and Measure Testosterone

• Obtain morning total testosterone (before 10 AM due to diurnal variation) 3, 1, 2
• Confirm with at least two measurements on separate days 3
• Consider free or bioavailable testosterone if total testosterone is borderline, especially since sex hormone-binding globulin decreases with diabetes and obesity 2, 4

Key diagnostic insight: DHEA-S has excellent diagnostic performance for adrenal insufficiency with AUROC 0.81, and a normal age- and gender-specific DHEA-S level makes corticotropin deficiency extremely unlikely 5, 6. However, when DHEA-S is low, further testing is mandatory.

Step 2: Distinguish Primary from Secondary Dysfunction

Measure LH and FSH to differentiate:

• Primary hypogonadism: Low testosterone with elevated LH/FSH (testicular failure) 3, 1
• Secondary hypogonadism: Low testosterone with low or inappropriately normal LH/FSH (hypothalamic-pituitary dysfunction) 3, 1

Critical distinction: This determines treatment options. Secondary hypogonadism patients can potentially achieve both fertility and normal testosterone with gonadotropin therapy, while primary hypogonadism patients require testosterone replacement only, which suppresses fertility 1.

Step 3: Evaluate for Adrenal Insufficiency

If DHEA-S is markedly low (especially <25 mcg/dL in context of other findings):

• Measure morning cortisol (before 9 AM) 5
• Check ACTH level to distinguish primary from secondary adrenal insufficiency 7

Diagnostic thresholds 5:

• Baseline cortisol ≥10 mcg/dL: Only 1.2% have adrenal insufficiency
• Baseline cortisol 5-9.9 mcg/dL + DHEA-S ≥60 mcg/dL: Only 1.3% have adrenal insufficiency
• Baseline cortisol <5 mcg/dL + DHEA-S <25 mcg/dL: 72.2% have adrenal insufficiency

If cortisol is borderline (5-10 mcg/dL), proceed to cosyntropin stimulation testing 5, 6.

Step 4: Screen for Underlying Causes

• Pituitary imaging (MRI) if secondary hypogonadism or adrenal insufficiency is confirmed 1
• Metabolic evaluation: fasting glucose, HbA1c, lipid panel, BMI, waist circumference 1
• Assess for HIV if risk factors present 4
• Consider adrenal imaging if clinical suspicion for adrenal pathology 8

Management Strategy

For Functional Hypogonadism (Most Common)

Lifestyle modification is first-line 1:

• Weight loss through low-calorie diet can reverse obesity-associated secondary hypogonadism
• Physical activity shows benefits correlating with exercise duration and weight loss
• However, testosterone increases are modest (1-2 nmol/L)

Important caveat: While lifestyle changes are essential, evidence suggests combining these with testosterone therapy yields better outcomes in symptomatic patients 1.

For Confirmed Hypogonadism with Symptoms

Testosterone replacement therapy is indicated when 3, 1, 2:

• Confirmed low testosterone on two separate morning measurements
• Presence of symptoms (decreased libido, erectile dysfunction, fatigue, decreased muscle mass)
• No contraindications (prostate cancer, severe heart failure, untreated sleep apnea, polycythemia)

Treatment goal: Raise testosterone to mid-normal range 3

Available formulations 3:

• Injectable testosterone (enanthate/cypionate): Check levels midway between injections
• Transdermal gel: Assess after 1 week of treatment
• Transdermal patch: Check 3-12 hours after application
• Buccal tablets: Check immediately before/after fresh system

For Secondary Hypogonadism with Fertility Concerns

Gonadotropin therapy is standard 1:

• Recombinant hCG and FSH
• Combined therapy provides optimal outcomes
• Testosterone therapy is contraindicated as it suppresses the HPG axis and compromises fertility 1

For Adrenal Insufficiency

If confirmed, requires glucocorticoid and mineralocorticoid replacement 9:

• Hydrocortisone 15-25 mg daily in divided doses
• Fludrocortisone 0.05-0.1 mg daily if primary adrenal insufficiency

Consider DHEA replacement in women with persistent symptoms despite optimized therapy (25 mg daily for 6-month trial), though evidence in men is limited 9, 10.

Monitoring Requirements

For patients on testosterone therapy 3:

At 3 months, then annually:

• Symptom response assessment
• Hematocrit (stop if >54%)
• Digital rectal exam and PSA (in accordance with age-appropriate screening)
• Testosterone levels (adjust to maintain mid-normal range)

Cardiovascular risk consideration: Testosterone replacement in older men has been associated with increased coronary artery plaque volume and cardiovascular events in some studies—weigh risks versus benefits carefully 2.

Common Pitfalls to Avoid

1. Testing during acute illness: This suppresses the axis and yields false-positive results 1
2. Single testosterone measurement: Always confirm with at least two separate morning samples 3
3. Ignoring obesity as confounder: Obesity commonly causes functional hypogonadism that may respond to weight loss 1, 2
4. Starting testosterone in men desiring fertility: This suppresses spermatogenesis 1
5. Treating asymptomatic men: Treatment benefit is controversial without symptoms 2, 4
6. Measuring only total testosterone in obese/diabetic men: Check free or bioavailable testosterone as SHBG is often low 2